Jyothy Labs Ltd - 532926 - Closure of Trading Window
Closure of Trading Window for purchase/ sale of shares of the Company31-12-2021
31-12-2021
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201515-12-2021
Jyothy Labs Ltd - 532926 - Related Party Transaction Disclosure For The Half Year Ended September 30, 2021
Related Party Transaction Disclosure for the half year ended September 30, 202115-11-2021
Buy Jyothy Labs: target of Rs 190: Sharekhan
Sharekhan is bullish on Jyothy Labs has recommended buy rating on the stock with a target price of Rs 190 in its research report dated November 03, 2021.08-11-2021
Neutral Jyothy Laboratories; target of Rs 160: Motilal Oswal
Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 160 in its research report dated Novemer 02, 2021.03-11-2021
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication - Un-audited Financial Results of the Company for the quarter and half year ended September 30, 202103-11-2021
Earnings Call for Q2FY22 of Jyothy Labs
Conference Call with Jyothy Labs Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.02-11-2021
Q2FY22 Quarterly Result Announced for Jyothy Labs Ltd.
RESULT HIGHLIGHTS Revenue at Rs 585.4 Crores increase by 16% (FMCG Volume growth of 11.4% ) Gross Margin at 40.1% from 47.7% in the same period last year A&P; Spend at Rs 40.7 Crores (6.9% of Net Sales) versus Rs 30 Crores (5.9% of Net Sales) in the same period last year, an increase by 35.5% Operating EBITDA at 11.4% (Rs 66.6 Crores) versus 17.3% (Rs 87.4 Crores) in the same period last year. PAT at Rs 44 Crores as against Rs 60.1 Crores, in the same period last year. Revenue at Rs 1,111 Crores increase by 18.5% (FMCG Volume growth of 13.9%) Gross Margin at 41.6% from 47% in the same period last year A&P; Spend at Rs 83.6 Crores (7.5% of Net Sales) versus Rs 50 Crores (5.3% of Net Sales) in the same period last year, an increase by 67.4% Operating EBITDA at 11.7% (Rs 129.8 Crores) versus 17.5% (Rs 163.8 Crores), in the same period last year PAT at Rs 84.2 Crores as against Rs 110.1 Crores, in the same period last year Result PDF02-11-2021
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached herewith a copy of Presentation on the Company's performance for the quarter and half year ended September 30, 202102-11-2021